Recombinant Human sCD23 (FCER2)
Catalog No : IGX-RP499
1701.11€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
Product name | Recombinant Human sCD23 (FCER2) | ||
---|---|---|---|
Catalog No | IGX-RP499 | ||
Supplier’s Catalog No | IGX-RP499 | ||
Supplier | ImuGeX | ||
Source antigen | E. coli | ||
Reactivity | Human | ||
Cross reactivity | |||
Applications | |||
Molecular weight | 19.5 |
Storage | -70°C | ||
---|---|---|---|
Other names | Low affinity immunoglobulin epsilon Fc receptor, BLAST-2, Fc-epsilon-RII, Immunoglobulin E-binding factor, Lymphocyte IgE receptor, CD23, B cell differentiation antigen<br/>Recombinant Human C-type Lectin Domain Family 4 Member J (FCER2) | ||
Grade | Highly Purified | ||
Purity | >95% as determined by SDS-PAGE | ||
Form | Lyophilized from a 0.2 ÃŽ¼m filtered solution in PBS | ||
Reactivity life | 6 months | ||
Note | For reserch purpose only | ||
Purity | >95% as determined by SDS-PAGE | ||
Description | CD23 is a calcium dependent transmembrane glycoprotein which is expressed in many cell types. The cytoplasmic region of the protein has two isoforms – the 'a' isoform that participates in IgE-regulated endocytosis, and the 'b' isoform, which is involved in IgE-regulated phagocytosis. It has been found that there are at least four soluble forms of the CD23 protein (sCD23) all of which are produced by the activity of metallo/cysteine proteases. In addition to binding IgE, sCD23 have been shown to promote the activation and differentiation of B-cells and stimulate the release of pro-inflammatory cytokines from monocytes. |
© 2020 Imugex All Rights Reserved